Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation

被引:40
|
作者
Zhong, Jim [1 ,4 ]
Switchenko, Jeffrey [2 ,4 ]
Jegadeesh, Naresh K. [1 ,4 ]
Cassidy, Richard J. [1 ,4 ]
Gillespie, Theresa W. [3 ,4 ]
Master, Viraj [4 ,5 ]
Nieh, Peter [4 ,5 ]
Alemozaffar, Mehrdad [4 ,5 ]
Kucuk, Omer [4 ,6 ]
Carthon, Bradley [4 ,6 ]
Filson, Christopher P. [4 ,5 ,7 ]
Bilen, Mehmet A. [4 ,6 ]
Jani, Ashesh B. [1 ,4 ]
机构
[1] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Surg, Atlanta, GA 30322 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Dept Urol, Decatur, GA USA
[6] Dept Hematol & Oncol, Decatur, GA USA
[7] Atlanta Vet Affairs Med Ctr, Decatur, GA USA
关键词
MIBC; trimodality therapy; bladder-preservation therapy; bladder cancer; COMBINED-MODALITY THERAPY; LONG-TERM OUTCOMES; NEOADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; POOLED ANALYSIS; II TRIAL; PHASE; RADIOTHERAPY; CISPLATIN; SURVIVAL;
D O I
10.1097/COC.0000000000000471
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radical cystectomy currently remains the standard of care for muscle-invasive bladder cancer. However, surgery can be associated with considerable morbidity and mortality, including the removal of the bladder. An alternative strategy is to preserve the bladder through concurrent chemoradiation following a maximal transurethral resection of the tumor. National protocols using a bladder-preservation approach have demonstrated disease-specific outcomes comparable to radical cystectomy in selected patients, but these results have not been replicated in previously reported population-based series. Here, we describe an outcomes analysis of patients with muscle-invasive bladder cancer treated with either radical surgery or bladder-preserving chemoradiation (BPCRT) for those patients meeting BPCRT criterion using the National Cancer Database (NCDB). Materials and Methods: Using the NCDB, patients with American Joint Commission on Cancer clinical T2-3, N0, M0 urothelial carcinoma diagnosed between 2004 and 2013 were included for analysis. Only patients treated with definitive intent with either radical cystectomy or concurrent chemotherapy and radiation after a maximal transurethral tumor resection were included. Propensity-score matching was used. Results: Among 8454 eligible patients, 7276 (86%) underwent radical cystectomy, and 1178 (14%) underwent BPCRT. Patients undergoing BPCRT were significantly older (median age, 77 vs. 68 y; P<0.001) and had higher Charlson-Deyo comorbidity scores (P=0.002). Using propensity-matched analysis, 1002 patients remained in each cohort, and there was no significant difference in survival found between the 2 cohorts (median overall survival, 2.7 vs. 3.0 y [P=0.20]; 4-year overall survival, 39.1% and 42.6% [P=0.15], for BPCRT and surgery, respectively). In addition, the hazard ratio (HR) of surgery versus BPCRT decreased over time, with an initial HR of 1.27 favoring BPCRT which decreased by a factor of 0.85 per year. Conclusions: From 2004 to 2013, similar to 14% of patients from the NCDB who potentially met bladder-preservation criteria underwent the procedure. Our propensity-matched analysis is the only report of its kind to demonstrate similar survival outcomes with bladder preservation when patients are properly selected. This study is also the first to demonstrate a dynamic HR between radical surgery and BPCRT over time.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [41] Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
    Kumar, Abhishek
    Cherry, Daniel R.
    Courtney, Patrick T.
    Nalawade, Vinit
    Kotha, Nikhil
    Riviere, Paul J.
    Efstathiou, Jason
    McKay, Rana R.
    Kader, A. Karim
    Rose, Brent S.
    Stewart, Tyler F.
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2021, 30 : 1 - 10
  • [42] Salvage cystectomy after organ preservation treatment in patients with muscle-invasive bladder cancer
    Volkova, M. I.
    Tkhakokhov, M. M.
    Chernyaev, V. A.
    Figurin, K. M.
    Romanov, V. A.
    Kalinin, S. A.
    Peters, M. V.
    Evsyukova, O. I.
    Matveev, V. B.
    [J]. ONKOUROLOGIYA, 2016, 12 (04): : 131 - 141
  • [43] ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
    Gakis, Georgios
    Efstathiou, Jason
    Lerner, Seth P.
    Cookson, Michael S.
    Keegan, Kirk A.
    Guru, Khurshid A.
    Shipley, William U.
    Heidenreich, Axel
    Schoenberg, Mark P.
    Sagaloswky, Arthur I.
    Soloway, Mark S.
    Stenzl, Arnulf
    [J]. EUROPEAN UROLOGY, 2013, 63 (01) : 45 - 57
  • [44] Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer
    Williams, Stephen B.
    Shan, Yong
    Ray-Zack, Mohamed D.
    Hudgins, Hogan K.
    Jazzar, Usama
    Tyler, Douglas S.
    Freedland, Stephen J.
    Swanson, Todd A.
    Baillargeon, Jacques G.
    Hu, Jim C.
    Kaul, Sapna
    Kamat, Ashish M.
    Gore, John L.
    Mehta, Hemalkumar B.
    [J]. JAMA SURGERY, 2019, 154 (08)
  • [45] Re: Comparison of Radical Cystectomy with Conservative Treatment in Geriatric (≥80) Patients with Muscle-Invasive Bladder Cancer
    Griebling, Tomas L.
    [J]. JOURNAL OF UROLOGY, 2014, 192 (02): : 372 - 372
  • [46] Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer
    Pignot, G.
    Sargos, P.
    [J]. PROGRES EN UROLOGIE, 2021, 31 (03): : 158 - 168
  • [47] Urinary Diversion After Radical Cystectomy for Muscle-Invasive Bladder Cancer
    Hakenberg, Oliver W.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (10) : 735 - 735
  • [48] Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy
    Salama, Asmaa
    Abdelmaksoud, Abdelmaksoud M.
    Shawki, Ashraf
    Abdelbary, Ahmad
    Aboulkassem, Hatem
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E43 - E47
  • [49] Alternatives to cystectomy in muscle-invasive bladder cancer
    Goel, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 3003 - 3003
  • [50] Re: Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (03): : 497 - 497